Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05498103
PHASE4
Use of Methazolamide to Lower Intraocular Pressure
Sponsor: University of Colorado, Denver
View on ClinicalTrials.gov
Summary
The purpose of this study is to evaluate the effect of methazolamide, 25 mg or 50 mg tablets once a day for a week than twice a day for a week, on lowering intraocular pressure and the safety of methazolamide.
Key Details
Gender
All
Age Range
50 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2023-02-17
Completion Date
2024-12
Last Updated
2024-02-06
Healthy Volunteers
No
Conditions
Interventions
DRUG
Methazolamide 25 MG
25 mg tablets
DRUG
Methazolamide 50 MG
50 mg tablets
Locations (1)
Sue Anschutz-Rodgers Eye Center
Aurora, Colorado, United States